insights_auto
Why is GH down 2,24%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
164,56 $
arrow_downward
-2,24%(-3,77) 1D
8 հոկ, 15:23:32 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
166,24 $
High
167,28 $
Low
161,61 $
Mkt. cap
22,08 մլրդ
Avg. vol.
1,89 մլն
Volume
1,10 մլն
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
Open
166,24 $
High
167,28 $
Low
161,61 $
Mkt. cap
22,08 մլրդ
Avg. vol.
1,89 մլն
Volume
1,10 մլն
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Simply Wall Street
·
1 օր առաջ
How Positive Melanoma Test Data Will Impact Guardant Health Stock
Yahoo Finance
·
1 օր առաջ
Guardant Health, Inc. (GH) Stock Forecasts
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteguardanthealth.com